Cancer Research UK web site, latest news and contact details

Address:
61 Lincoln's Inn Fields
London
WC2A 3PX
UK
Telephone: (UK) +44 20 7009 8820

Listing of all 71 news releases from Cancer Research UK:

CRT opens drug discovery laboratory in Cambridge

User application article This is the first multi-disciplinary discovery laboratory for CRT to be established outside the main London laboratory at UCL's Wolfson Institute for Biomedical Research

News from Cancer Research UK (16 May 2008)

CRT licenses antibody technology to Glycart

Specialist oncology-focused development and commercialisation company has granted an exclusive worldwide licence to Glycart Biotechnology to develop a preclinical antibody for the treatment of cancer

News from Cancer Research UK (18 January 2008)

Funding doubles in cancer research

Cancer Research UK funded a record Ł315m of research last year, marking a near doubling in research funding since the charity was formed five years ago

News from Cancer Research UK (17 September 2007)

Novozymes, UCL, and CRT conclude collaboration

The collaboration will generate anti-CEA scFv molecules which will be genetically fused with albumin using Novozymes proprietary Albufuse technology for future therapeutic or preventive applications.

News from Cancer Research UK (11 September 2007)

Research collaboration in tumour imaging

The three-year research collaboration will be funded by AstraZeneca and focus on the development of cutting-edge real-time fluorescence and confocal imaging techniques

News from Cancer Research UK (18 July 2007)

Scientist wins award for cancer diagnostic markers

Technical background article MCM proteins found to have potential as the basis of simple non-invasive tests for a range of cancers, including cervical, bladder, colorectal, lung, and cancer of the oesophagus

News from Cancer Research UK (25 June 2007)

Biomarker alliance with AstraZeneca

Cancer Research Technology and the University of Manchester announce the establishment of an alliance with AstraZeneca to develop serological pharmacodynamic (PD) biomarkers

News from Cancer Research UK ( 5 June 2007)

Cancer Research Technology laboratories to expand

The development laboratories, working on an industrial model in collaboration with the originating academics, will double in size with the number of scientists increasing from about 45 to 90

News from Cancer Research UK ( 9 May 2007)

CRT licenses therapeutic antibodies to Peptech

Cancer Research Technology (CRT), the oncology-focused development and commercialisation company, has licensed rights to a panel of cancer therapeutic antibodies to Peptech

News from Cancer Research UK ( 3 May 2007)

Pioneering cancer expert appointed chief scientist

Cancer Research UK has appointed world-leading cancer researcher Professor Sir David Lane as its first chief scientist

News from Cancer Research UK ( 5 April 2007)

New CEO to spearhead CRT laboratory expansion

Keith Blundy, 46, joined CRT - Cancer Research UK's development and commercialisation company - in 1998 and has been the company's chief operating officer since November 2003

News from Cancer Research UK ( 3 April 2007)

Oncology-focused drug discovery collaboration

Technical background article Cancer Research Technology (CRT ) and Fox Chase Cancer Center announce the initiation of an oncology-focused drug discovery collaboration

News from Cancer Research UK ( 2 March 2007)

CRT grants Waypharm an option to platinum agents

Technical background article Waypharm has secured rights to evaluate Thioplatin a novel hypoxia-responsive platinum-based cancer therapy, from Cancer Research Technology

News from Cancer Research UK ( 6 February 2007)

Australian cooperation in cancer therapy

Technical background article Seven of Australia's leading research organisations plus Cancer Research Technology, Bionomics, and Millipore/Chemicon, are forming the Cooperative Research Centre for Cancer Therapeutics (CRC-CT)

News from Cancer Research UK (30 January 2007)

Clinical pharmacology collaboration in oncology

Cancer Research Technology and the University of Manchester announce a clinical pharmacology collaboration in oncology with AstraZeneca

News from Cancer Research UK (21 November 2006)

CRT to present discovery updates at BioEurope 2006

Cancer Research Technology, the oncology-focused development and commercialisation company, says that Phil L'Huillier will present at the BioEurope 2006 annual international partnering conference

News from Cancer Research UK ( 8 November 2006)

Distribution rights of RNA interference library

User application article CRT grants Geneservice a worldwide exclusive licence to distribute the pSuper RNAi vector system and pRetrosuper vector-based shRNA library generated at the Netherlands Cancer Institute (NKI)

News from Cancer Research UK (28 September 2006)

Anti-cancer studies of nanoparticle photodynamics

Cancer Research Technology, University of East Anglia, and University of Padua collaborate focusing on proof of concept anti-cancer studies of an exciting nanoparticle-based photodynamic therapy (PDT)

News from Cancer Research UK ( 8 September 2006)

Colorectal cancer collaboration with AstraZeneca

Cancer Research Technology (CRT), has entered into an agreement with AstraZeneca focused on colorectal cancer

News from Cancer Research UK ( 5 September 2006)

Novel protein-genome interaction mapping system

Technical background article DamID, developed at Fred Hutchinson Cancer Research Center and the NKI, maps protein-genome interactions using tethered DNA adenine methyltransferase to create unique tags, which mark binding sites